FDA Approves Novo Nordisk Obesity Drug
by DiabetesCare.net | Jan 4, 2023
The U.S. Food and Drug Administration (FDA) recently approved Saxenda, an injectable drug developed by Novo Nordisk. Although Saxenda is a formulation of the type 2 diabetes drug, liraglutide, also known as Victoza, Saxenda has been indicated for the treatment of weight management only. Saxenda is not for the treatment of type 2, but is looking to lend a...
Pill Decreases Blood Glucose by 30 Percent
by DiabetesCare.net | Jan 4, 2023
Scientists from Cornell University saw promising results in an animal study that could one day lead to the creation of a probiotic pill that can help control blood glucose. Researchers treated rats with type 2 diabetes with an oral probiotic for 90 days. The animals treated with the probiotic had up to 30 percent lower blood glucose after 3 months. The...
Metformin is Rarely Prescribed in People with Prediabetes
by DiabetesCare.net | Jan 4, 2023
Metformin, a drug used to treat type 2 diabetes, may be underused in the prevention of the chronic disease, according to a recent study conducted by researchers at UCLA. Their study showed that throughout a three year span, 2010-2012, only 3.7 percent of U.S. adults with prediabetes were prescribed metformin. “Metformin is rarely being used for diabetes...
FDA Warns that Class of Drug Could Lead to Too Much Acid in the Blood
by DiabetesCare.net | Jan 4, 2023
The U.S. Food and Drug Administration (FDA) recently announced that a certain class of drug can lead to increased levels of acid in the blood. Canaglifozin, dapaglifozin, and empagliflozin are considered a class of drug called sodium-glucose cotransporter-2 (SGLT2) inhibitors. This class of drug is prescribed for people with type 2 diabetes. However the...
Vaccine for Type 1 Advances
by DiabetesCare.net | Jan 4, 2023
An existing vaccination drug, Calmette-Guerin (BCG), has now been approved by the FDA for the start of phase II of a trial to determine the vaccine’s effectiveness in the treatment of type 1 diabetes. The announcement was made last week at the 75th Scientific Sessions of the American Diabetes Assoication (ADA). The generic drug has been in use for decades...
